期刊文献+

反应停对慢性肝炎患者外周血单核细胞肿瘤坏死因子α的抑制作用 被引量:1

Inhibition of Thalidomide on Tumor Necrosis Factor α and Other Cytokins Produce d by Human Peripheral Blood Mononuclear Cells from Patients with Chronic Hepatitis
下载PDF
导出
摘要 目的 观察反应停对慢性肝炎的治疗作用。方法 用淋巴细胞份离液从 13例慢性肝炎患者的外周血中分离单核细胞 ( peripheralbloodmononuclearcells,PBMCs)进行体外培养 ,用酶联免疫吸附法、免疫组化法观察反应停对PBMCs肿瘤坏死因子α(TNFα)和其他细胞因子产生的影响。结果 反应停可抑制PBMCsTNFα和其他细胞因子的产生。结论 反应停对慢性肝炎的治疗有重要的意义。 ObjectiveTo observe the treatment effects of Thali domide on the patients with chronic hepatitis.MethodsPeripheral blood mononuclear cells (PBMCs) were isolated from 13 patients with chronic hepa titis by density gradient centrifugtion, then cultured in vitro, the effects of Thalidomide on the syntheses and secretion of TNF-α, IL-1α,IL-6, IL-8 were st udied with enzyme-linked immunosorbent assay and immunohistochemical method.ResultsThalidomide could reduce the syntheses and secretions of TNF- αP<0.05) and other cytokines, including IL-1α, IL-6 and IL-8 induced by L PS (P<0.05)ConclusionsThalidomide or its analogues could be as a new therapeutic drug to treating chronic hepatitis.
出处 《齐齐哈尔医学院学报》 2001年第10期1119-1120,共2页 Journal of Qiqihar Medical University
关键词 反应停 慢性肝炎 外周血单核细胞 肿瘤坏死因子Α Thalidomide Chronic hepatitis TNF-α Peripheral blood mononuclear cell
  • 相关文献

参考文献2

二级参考文献4

  • 1黄芬,中国医科大学学报,1993年,22卷,275页
  • 2张定风,中华医学杂志,1990年,70卷,438页
  • 3陈梅龄,中华内科杂志,1985年,23卷,增刊,30页
  • 4李平,中华内科杂志,1984年,23卷,340页

共引文献72

同被引文献18

  • 1Connelius HG, Nommann SL. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumors asites. J Immunol, 1998,141 : 2175.
  • 2Spittler A, Razenberger M, Kupper H, et al. Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin Infect Dis,2000,31 : 1338-1420.
  • 3Ye Q,Chen B,Tong Z,et al. Thalidomide reduces IL-18 ,IL-8 and TNF-a release from alveolar macrophages in interstitial lung disease. European Respiratory Journal ,2006,28 : 824-831.
  • 4金惠铭,王建枝主编.病理生理学.第7版.北京:人民出版社,2001.101-103.
  • 5Deng L, Ding W, Granstein RD. Thalidomide inhibits tumor necrosis factor2-ct production and antigen presentation by Langerhans cells. Invest Dermatol,2003 ,121:33-41.
  • 6Michael E, Gordon RM, William DF. Thalidomide. Lancet, 2004,363 : 1802.
  • 7Noman A, Koide N, Hassan F, et al. Thalidomide inhibits lipopolysaccharide -induced tumor necrosis factor-a production via down-regulation of MyD88 expression:Innate Immun,2009,15:33-41.
  • 8Figg WD. Development of thalidomide as an angi ogenesis inhibit or for the treat ment of andr ogen2independent prostate cancer. Clin Phar macol Ther,2006,79 : 1-8.
  • 9Komorowski J, Jerczynska H, Siejka A, et al. Effect of thalidomide affecting VEGF secreti on,cell migrati on, adhesi on and cap illary tube for mati on of human endothelial EA. Hy 926 cells. Life Sci,2005,78:2558 -2563.
  • 10Payvandi F, Wu L. Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-α, IL-1β, and LPS-stimulated human PBMC in a partially IL-10-dependent manner. Cellular Immunology, 2004, 230:81-88.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部